Pharmaceutical risk management: Protect
your investments

Proactive clinical risk management is absolutely vital for every organization in today’s fast-moving global marketplace.  Companies that fail to properly anticipate and mitigate their risks are endangering their business assets, the jobs of their employees, and even their continued existence.  For a biopharmaceutical company, products in development and on the market are its most valuable assets.  The best way to protect those assets – and protect the safety of patients – is to thoroughly understand the safety and risk of every product.

Although most pharmaceutical risk management efforts in the past were focused on monitoring drug safety data from patients and prescribers after a product reaches the market, the concept of clinical risk management and mitigation has greatly expanded beyond post-marketing pharmacovigilance in recent years to encompass every stage of product development.  It is now generally agreed that the evaluation of safety and risk should begin at the earliest stages of drug discovery.  The more that is understood about a product’s risks early in the development process, the better the decisions will be about how to appropriately manage risk for a specific indication and target population.  It is also clear that a product’s risk profile evolves over time, which means that risk management must continue throughout a product’s lifecycle.

Clinical risk management experience

PAREXEL’s experience across every phase of pharmaceutical clinical development, combined with a wealth of expertise in global risk management and regulatory affairs, gives us the ability to  help any biopharmaceutical company establish a corporate-wide “safety culture” that integrates a qualitative risk assessment approach into every stage of pharmaceutical product development. With this comprehensive approach, a biopharmaceutical company can transform traditional pharmacovigilance into a proactive risk management strategy that reduces costs, increases patient safety, protects vital business assets, and enhances value for all of its stakeholders.